| 000 | 01398 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516130424.0 | ||
| 264 | 0 | _c20130909 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1878-0938 | ||
| 024 | 7 |
_a10.1016/j.carrev.2012.11.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodriguez, Alfredo E | |
| 245 | 0 | 0 |
_aAre drug-eluting stents superior to bare metal stents when compared to coronary artery bypass surgery? Show me the data. _h[electronic resource] |
| 260 |
_bCardiovascular revascularization medicine : including molecular interventions _c |
||
| 300 |
_a90-2 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCoronary Artery Bypass _xadverse effects |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xmortality |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetals |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 | _aProsthesis Design |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aStents |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tCardiovascular revascularization medicine : including molecular interventions _gvol. 14 _gno. 2 _gp. 90-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.carrev.2012.11.002 _zAvailable from publisher's website |
| 999 |
_c22394198 _d22394198 |
||